MT-201

· Mirador Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MT-201, covering 2025-11-04 to 2025-11-04. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-Human Single and Multiple Ascending Dose Study of MT-201 [Phase 1]